video corpo

LT033 RIQAS Explained
1 / 64Pages

Catalog excerpts

LT033 RIQAS Explained - 1

RANDOX INTERNATIONAL QUALITY ASSESSMENT SCHEME

Open the catalog to page 1
LT033 RIQAS Explained - 2

RIQAS THE LARGEST INTERNATIONAL EQA SCHEME WITH OVER 55,000 LAB PARTICIPANTS

Open the catalog to page 2
LT033 RIQAS Explained - 3

RIQAS REPORTS WEB-BASED DATA TRANSFER STANDARD REPORT END-OF-CYCLE REPORT MULTI-INSTRUMENT REPORT URINE TOXICOLOGY REPORT URINALYSIS REPORT SEROLOGY REPORT SERUM INDICES REPORT BACTERIAL IDENTIFICATION REPORT RIQAS PROGRAMMES PARAMETER INDEX

Open the catalog to page 3
LT033 RIQAS Explained - 4

BENEFITS Delivering a comprehensive yet cost effective EQA solution, RIQAS will help meet regulatory requirements and increase confidence in test system accuracy. Large Database of Users • A high level of participation means peer group numbers are maximised whilst ensuring availability of data for a wide range of instruments and methods. User-friendly Reports • Simple, one page per parameter format, enables at-a-glance performance assessment, saving valuable laboratory time. • Complimentary multi-instrument and interlaboratory reports allow comparative performance assessment of all...

Open the catalog to page 4
LT033 RIQAS Explained - 5

RIQAS Programmes • Ammonia/Ethanol • Anti-Mullerian Hormone (AMH) • Anti-TSH Receptor • Blood Gas • BNP • Cardiac • Cardiac Plus • Cerebrospinal Fluid (CSF) • Clinical Chemistry • Coagulation • CO-Oximetry • CYFRA 21-1 • Cytokines ESR Glycated Haemoglobin (HbA1c) • Haematology • Human Urine • Immunoassay • Immunoassay Speciality 1 • Immunoassay Speciality 2 • Immunosuppressant Drugs • Lipids • Maternal Screening Microbiology (Bacterial Identification) • Neonatal Bilirubin • Serology (Anti-SARS-CoV-2) • Serology Epstein Barr Virus (EBV) • Serology (HIV/Hepatitis) • Serology (Syphilis) •...

Open the catalog to page 5
LT033 RIQAS Explained - 6

RIQAS REPORTS RIQAS reports are presented in a user-friendly, one page per parameter format. This allows easy interpretation of your analytical performance. RIQAS Reports • tatistical breakdown by all methods, your method S and, where applicable, your instrument, including running means for the last 10 samples. • ompare your instrument group, method group C and all methods using the histogram. • Identify trends, biases and precision problems using the visual charts. • The Target Score chart uniquely grades your performance in a moving window over the last 20 samples, including the previous...

Open the catalog to page 6
LT033 RIQAS Explained - 7

WEB-BASED DATA TRANSFER RIQAS.Net offers easy, direct access for the submission of results and retrieval of reports direct from the RIQAS host server. • Available in multiple languages. • Confidentiality and security is maintained through the use of password protected access. • Submit current, corrected and future results (normal policies apply), directly into the RIQAS database. Receipt of results is confirmed by e-mail. •Multi-lingual registration identifier provides simple identification of multiple registrations. • Additions and changes to assay details can be made quickly and easily...

Open the catalog to page 7
LT033 RIQAS Explained - 8

PARTICIPATION IN RIQAS Participation in RIQAS follows these simple steps: Order your RIQAS programmes through your local Randox Office or Distributor. Register the instruments and methods used in your lab on RIQAS.net or by completing the enrolment document. Enrolment documents are available from riqas.com and should be submitted 3 weeks before the cycle starts. Check RIQAS policies in method questionnaire. Analyse the sample on the recommended date, carefully following the instructions for use. Enter your results via RIQAS.Net and submit before the final deadline. Receive a set of numbered...

Open the catalog to page 8
LT033 RIQAS Explained - 9

STANDARD REPORT Performance data is presented in a one page format with up to seven sub-reports. )NWEQUG OIFN #EEGRVCDNG NKOKVU FGTKXGF HTQO $KQNQIKECN 8CTKCVKQP #EEGRVCDNG NKOKVU QH RGTHQTOCPEG HQT 4+3#5 *GZQMKPCUG )NWEQUG QZKFCUG 1TVJQ 8KVTQU /KETQ5NKFG 5[UVGOU )NWEQUG FGJ[FTQIGPCUG )1&$GEMOCP OGVJQF 1VJGT &T[ %JGOKUVT[ #ICRRG )1&2#2 1Z[IGP GNGEVTQFG 8KVTQU &6&6 ++ Text Section Chart: Statistics for all methods, your method and instrument group (programme specific). Histogram Chart: Method and instrument comparison. Multi-Method Stat Section Chart: Enables assessment of the performance of...

Open the catalog to page 9
LT033 RIQAS Explained - 10

TEXT SECTION The text section summarises the statistical information for each parameter. /106*.; %.+0+%#. %*'/+564; )NWEQUG OIFN RIQAS performance indicators include SDI, Target Score and %Deviation. Acceptable performance criteria: 6&2# SDI < 2 Target score 50 %Deviation ≤ defined acceptable limits #EEGRVCDNG NKOKVU QH RGTHQTOCPEG HQT 4+3#5 #EEGRVCDNG NKOKVU FGTKXGF HTQO $KQNQIKECN 8CTKCVKQP Performance statement appears here if performance indicators exceed limits Number of returned results used to generate Mean for Comparison. After statistical reduction, some results are excluded from...

Open the catalog to page 10
LT033 RIQAS Explained - 11

/GCP/GCP HQT %QORCTKUQP HQT %QORCTKUQP The Bar Graph is intended as a quick visualisation of how your lab’s result compares to the method mean, instrument mean and all method mean. Your instrument group (programme specific) Your method group #EEGRVCDNG NKOKVU NKOKVU QH RGTHQTOCPEG4+3#5 #EEGRVCDNG QH RGTHQTOCPEG HQT HQT 4+3#5 #EEGRVCDNG NKOKVU NKOKVU FGTKXGF $KQNQIKECN 8CTKCVKQP #EEGRVCDNG FGTKXGF HTQO HTQO $KQNQIKECN 8CTKCVKQP *GZQMKPCUG *GZQMKPCUG )NWEQUG QZKFCUG )NWEQUG QZKFCUG 1TVJQ 1TVJQ 8KVTQU /KETQ5NKFG 5[UVGOU 8KVTQU /KETQ5NKFG 5[UVGOU )NWEQUG FGJ[FTQIGPCUG )NWEQUG FGJ[FTQIGPCUG...

Open the catalog to page 11
LT033 RIQAS Explained - 12

This section provides an easy way of assessing the performance of other methods used to analyse the parameter in question. Hexokinase Glucose oxidase Ortho Vitros MicroSlide Systems Glucose dehydrogenase GOD/02-Beckman method Other Dry Chemistry Agappe - GOD-PAP Oxygen electrode Vitros, DT60/DT60 II

Open the catalog to page 12
LT033 RIQAS Explained - 13

LEVEY-JENNINGS CHART SDIs reflect laboratory performance in relation to fit-for-purpose SDPAs and are useful to monitor performance over time. Acceptable performance is SDI < 2. N = No result returned in time for this registration\sample. C = Corrected results will be accepted for non-analytical errors. Corrected results will be accepted up to 4 weeks after the final submission deadline, on application, with evidence of analysis. Late results are only accepted if there has been a Randox error. This line indicates change in registration details for this a parameter. Sample number. The Mean...

Open the catalog to page 13

All Randox Laboratories catalogs and technical brochures

  1. Acusera 24.7

    24 Pages

  2. sdLDL-C

    8 Pages

  3. RX modena

    20 Pages

  4. RX misano

    20 Pages

  5. Rx Imola

    20 Pages

  6. RX Monaco

    20 Pages

  7. VeraSTAT-V

    16 Pages

  8. VERASTAT

    16 Pages

  9. Qnostics

    52 Pages

  10. Linearity sets

    12 Pages

  11. Antioxidants

    16 Pages

  12. VIVALYTIC

    30 Pages

  13. HbA1c

    2 Pages

  14. Preparing QC

    1 Pages

Archived catalogs

  1. ACUSERA

    108 Pages

  2. Evidence

    16 Pages

  3. Rx Daytona

    16 Pages

  4. Evidence

    16 Pages